Anu Cherukuri

2.3k total citations
31 papers, 1.8k citations indexed

About

Anu Cherukuri is a scholar working on Immunology, Molecular Biology and Epidemiology. According to data from OpenAlex, Anu Cherukuri has authored 31 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 11 papers in Molecular Biology and 7 papers in Epidemiology. Recurrent topics in Anu Cherukuri's work include Immune Cell Function and Interaction (12 papers), T-cell and B-cell Immunology (7 papers) and Lipid Membrane Structure and Behavior (6 papers). Anu Cherukuri is often cited by papers focused on Immune Cell Function and Interaction (12 papers), T-cell and B-cell Immunology (7 papers) and Lipid Membrane Structure and Behavior (6 papers). Anu Cherukuri collaborates with scholars based in United States, United Kingdom and Germany. Anu Cherukuri's co-authors include Susan K. Pierce, Michelle Dykstra, Hae Won Sohn, Paul C. Cheng, Shiang‐Jong Tzeng, Susan K. Pierce, Susan K. Pierce, Stephen R. Brooks, Jennifer Woo and Kathryn Patton and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and Blood.

In The Last Decade

Anu Cherukuri

30 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anu Cherukuri United States 17 904 717 235 199 190 31 1.8k
John A. Gebe United States 25 945 1.0× 642 0.9× 163 0.7× 246 1.2× 225 1.2× 52 2.0k
Teresa A. Doggett United States 21 503 0.6× 788 1.1× 286 1.2× 98 0.5× 178 0.9× 30 1.8k
Frank Kolbinger Switzerland 25 1.1k 1.2× 648 0.9× 121 0.5× 385 1.9× 127 0.7× 50 2.1k
Vincenzo Di Bartolo France 28 1.4k 1.6× 722 1.0× 213 0.9× 183 0.9× 180 0.9× 52 2.2k
Catherina H. Bird Australia 20 950 1.1× 908 1.3× 240 1.0× 65 0.3× 190 1.0× 33 2.1k
Valérie Pinet France 17 1.6k 1.8× 587 0.8× 162 0.7× 161 0.8× 116 0.6× 27 2.1k
Sidorenko Sp Ukraine 19 1.3k 1.4× 743 1.0× 222 0.9× 198 1.0× 65 0.3× 45 2.0k
Luc Reininger Switzerland 27 1.3k 1.4× 539 0.8× 212 0.9× 586 2.9× 78 0.4× 54 2.2k
Nicolaas H. C. Brons Luxembourg 25 691 0.8× 701 1.0× 311 1.3× 136 0.7× 99 0.5× 56 2.1k

Countries citing papers authored by Anu Cherukuri

Since Specialization
Citations

This map shows the geographic impact of Anu Cherukuri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anu Cherukuri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anu Cherukuri more than expected).

Fields of papers citing papers by Anu Cherukuri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anu Cherukuri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anu Cherukuri. The network helps show where Anu Cherukuri may publish in the future.

Co-authorship network of co-authors of Anu Cherukuri

This figure shows the co-authorship network connecting the top 25 collaborators of Anu Cherukuri. A scholar is included among the top collaborators of Anu Cherukuri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anu Cherukuri. Anu Cherukuri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schulz, Angela, Nicola Specchio, Emily de los Reyes, et al.. (2023). Safety and efficacy of cerliponase alfa in children with neuronal ceroid lipofuscinosis type 2 (CLN2 disease): an open-label extension study. The Lancet Neurology. 23(1). 60–70. 15 indexed citations
2.
Pinkstaff, Jason, Emma McCullagh, Anita Grover, et al.. (2023). Safety, pharmacokinetics and CNS distribution of tralesinidase alfa administered via intracerebroventricular infusion to juvenile cynomolgus monkeys. Toxicology Reports. 10. 357–366.
3.
Larimore, Kevin, Anu Cherukuri, Kala Jayaram, et al.. (2021). Pharmacokinetics and Exposure–Response of Vosoritide in Children with Achondroplasia. Clinical Pharmacokinetics. 61(2). 263–280. 20 indexed citations
4.
Cherukuri, Anu, Heather Cahan, Peter Slasor, et al.. (2018). Immunogenicity to cerliponase alfa intracerebroventricular enzyme replacement therapy for CLN2 disease: Results from a Phase 1/2 study. Clinical Immunology. 197. 68–76. 25 indexed citations
5.
Sinclair, John, Rebecca E.H. Whiting, Grace O. Robinson, et al.. (2018). Intravitreal enzyme replacement therapy attenuates retinal disease progression in a canine model of neuronal ceroid lipofuscinosis type 2 (CLN2). Molecular Genetics and Metabolism. 123(2). S132–S132. 2 indexed citations
6.
Tang, Roderick S., Anu Cherukuri, Robert A. Gasser, et al.. (2013). Translational sciences approach to RSV vaccine development. Expert Review of Vaccines. 12(9). 1047–1060. 12 indexed citations
7.
Cherukuri, Anu, Kate L. Stokes, Kathryn Patton, et al.. (2012). An adjuvanted respiratory syncytial virus fusion protein induces protection in aged BALB/c mice. Immunity & Ageing. 9(1). 21–21. 32 indexed citations
8.
Cherukuri, Anu, Kathryn Patton, Robert A. Gasser, et al.. (2012). Adults 65 Years Old and Older Have Reduced Numbers of Functional Memory T Cells to Respiratory Syncytial Virus Fusion Protein. Clinical and Vaccine Immunology. 20(2). 239–247. 90 indexed citations
9.
Cherukuri, Anu, et al.. (2011). Vaccine-specific antibody secreting cells are a robust early marker of LAIV-induced B-cell response in ferrets. Vaccine. 30(2). 237–246. 9 indexed citations
10.
Barrington, Robert A., Ming Zhang, Xuemei Zhong, et al.. (2005). CD21/CD19 Coreceptor Signaling Promotes B Cell Survival during Primary Immune Responses. The Journal of Immunology. 175(5). 2859–2867. 38 indexed citations
11.
Cherukuri, Anu, Tsipi Shoham, Hae Won Sohn, et al.. (2004). The Tetraspanin CD81 Is Necessary for Partitioning of Coligated CD19/CD21-B Cell Antigen Receptor Complexes into Signaling-Active Lipid Rafts. The Journal of Immunology. 172(1). 370–380. 105 indexed citations
12.
Cherukuri, Anu, Robert H. Carter, Stephen R. Brooks, et al.. (2004). B Cell Signaling Is Regulated by Induced Palmitoylation of CD81. Journal of Biological Chemistry. 279(30). 31973–31982. 85 indexed citations
13.
Cherukuri, Anu, Paul C. Cheng, & Susan K. Pierce. (2001). The Role of the CD19/CD21 Complex in B Cell Processing and Presentation of Complement-Tagged Antigens. The Journal of Immunology. 167(1). 163–172. 144 indexed citations
14.
Cherukuri, Anu, Michelle Dykstra, & Susan K. Pierce. (2001). Floating the Raft Hypothesis. Immunity. 14(6). 657–660. 197 indexed citations
15.
Cheng, Paul C., Anu Cherukuri, Michelle Dykstra, et al.. (2001). Floating the raft hypothesis: the roles of lipid rafts in B cell antigen receptor function. Seminars in Immunology. 13(2). 107–114. 58 indexed citations
17.
18.
Cherukuri, Anu, et al.. (1998). Ligand binding specificity of a macrophage surface receptor utilized by the fluorescein hapten for uptake into the endocytic pathway. Molecular Immunology. 35(2). 115–125. 3 indexed citations
19.
Cherukuri, Anu, et al.. (1997). Evidence for hapten recognition in receptor-mediated intracellular uptake of a hapten-protein conjugate by murine macrophage. Molecular Immunology. 34(1). 21–32. 11 indexed citations
20.
Cherukuri, Anu, et al.. (1996). Macrophage mediated processing of an exogenous antigenic fluorescent probe: Time‐dependent elucidation of the processing pathway. Biology of the Cell. 87(1-2). 95–104. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026